Drug Process Licensing Associates launches pharma database
PHILL, which stands for PHarmaceutical InteLLigence, is a database of bulk drug and intermediates producer information pertinent to members of the chemical and pharmaceutical industry. It also includes regulatory information such as Drug Master Files, Veterinary Master Files, Certificates of Suitability and Drug Approvals.
DPLA (Drug Process Licensing Associates, LLC) is off and running again with the launch of their newest database product called PHILL. PHILL, which stands for PHarmaceutical InteLLigence, is a database of bulk drug and intermediates producer information pertinent to members of the chemical and pharmaceutical industry. It also includes regulatory information such as Drug Master Files, Veterinary Master Files, Certificates of Suitability and Drug Approvals.
After the successful filing of their API patents for manufacturing processes for Sitagliptin, Tadalafil, Tiotropium bromide and Pregabalin last year, PHILL is a new, first rate directory containing worldwide producers of active pharmaceutical ingredients and chemical intermediates. It is unrivaled not only in its quality, but in its breadth of content.
“PHILL contains information not seen in any other producer directories. We have included descriptive information on the producing companies themselves as well as information about their production of each product.” said Ron Schwarz, managing director and founder of DPLA. “Many other directories have been criticized for containing too many trading companies and for being out of date so we have taken great pains not to repeat the mistakes of our competitors.”
DPLA is also providing a lot of content free of charge as part of PHILL. "We wanted our colleagues in the industry to have access to important information such as DMFs, VMFs and CEPs so we have integrated this content with the producer information and are making it available to users completely free of charge,” chief operating officer, Julie Foster said. "Our competitors charge more than US$3,000 for this information, but not DPLA."
In addition to DMFs, VMFs and CEPs, the free modules of PHILL include Human and Animal Drug Approvals, Paragraph IV certifications, and FDA warning letters. The fee-based modules include worldwide producers, patents, and worldwide drug revenue. "PHILL is an incredible comprehensive resource, and the companies who use it are going to be very pleased with the results that they find," Schwarz said.
- Share this article
- Got more on this story? Email PharmaAsia
- More About
- Drug Manufacturing
- Regulatory and Legal
- QA/QC and Compliance
- Drug Process Licensing Associates










